D-0785-2021 Class III Terminated
FDA drug recall D-0785-2021 was initiated by Teligent Pharma, Inc. on Jul 29, 2021 and is designated Class III. Reason for recall: Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing. The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 114,456 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 8, 2021
- Initiation Date
- Jul 29, 2021
- Termination Date
- Aug 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 114,456 tubes
Product description
Lidocaine Ointment USP, 5% Rx Only, Net Wt 35.44 g(1 1/4 oz)packaged in a laminat tube, Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-008-14.
Reason for recall
Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot #: 15378, Exp 3/2023; 14418 EXP 10/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0785-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026